Prolonged survival after high-dose cytosine arabinoside and amsacrine induction in patients with previously untreated de novo acute nonlymphocytic leukemia

Semin Oncol. 1987 Jun;14(2 Suppl 1):37-9.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Disease
  • Amsacrine / administration & dosage*
  • Bone Marrow Transplantation
  • Cytarabine / administration & dosage*
  • Dose-Response Relationship, Drug
  • Humans
  • Leukemia / drug therapy*
  • Leukemia / therapy
  • Prognosis

Substances

  • Amsacrine
  • Cytarabine